Skip to main content

Table 2 Percentage of CDSs from chromosome of Eklund 17B (NRP) scored positive by microarray analysis of strains of Group II C. botulinum

From: Genomic and physiological variability within Group II (non-proteolytic) Clostridium botulinum

Strain Toxin subtype Clade Total number of CDSs present % of control CDSs present
Eklund 17B (NRP) B4 1 3384 100
Eklund 2B B4 1 3384 100
IFR 05/020 B4 1 3383 100
Colworth BL151 B4 1 3383 100
IFR 05/029 B4 2 2959 87
IFR 06/001 F6 2 2917 86
IFR 05/025 B4 2 2900 86
Eklund 202F F6 2 2863 85
2129B B4 2 2848 84
CDC 5900 B4 2 2846 84
ATCC 17844 B4 2 2845 84
Hobbs FT50 B4 2 2829 84
Kapchunka B2 B4 2 2806 83
CDC 4627 U-1 B4 2 2792 83
Kapchunka B5 B4 2 2777 82
Hobbs FT10 F6 2 2761 82
Craig 610 F6 2 2758 82
IFR 06/005 F6 2 2750 81
CDC 3875 B4 2 2716 80
CB-K-37E E1 3 2428 72
CB-K-32E E6 3 2424 72
CB-K-36E E6 3 2404 71
CB-K-24E E1 3 2403 71
IFR 02/050 E3 3 2403 71
CDC 8073 E2 3 2401 71
CB-K-23E E1 3 2351 69
Foster B96 E3 3 2292 68
CB-K-16E E1 3 2281 67
CB-S-3E E1 3 2276 67
CB-K-40E E3 3 2263 67
CB-S-27E NTE 3 2249 66
CB-K-18E E1 3 2242 66
Prevot P34 E3 3 2164 64
CB-K-34E E1 3 2120 63
CB-S-20E NTE 3 2095 62
CB-S-15E NTE 3 2072 61
Dolman VH E3 3 2064 61
Hazen 36208 E1 3 2058 61
CB-K-9E E6 3 2024 60
CB-K-3E E3 3 2023 60
CDC 7854 E1 3 2012 59
Beluga E1 3 1990 59
CB-K-19E E1 3 1946 58
  1. Sixty-mer probes were used to represent 3384 chromosomal sequences of Eklund 17B (NRP) on a microarray. Data show the number of these CDSs found in each test strain by microarray analysis. CDSs were considered to be present if the test probe signal was within 8-fold of the control probe signal and significantly above the background. NTE= no toxin gene detected but strain originally isolated containing type E neurotoxin gene.